Notice of Closed Meeting, 7760-7761 [2020-02691]

Download as PDF 7760 Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices 9,041 (5,168 + 3,435 + 438); (6) Annual Estimated Number of Total Responses: 9,041 (maximum of one response expected per user); (7) Annual Estimated Number of Burden Hours: It is estimated that it will take no more than 10 minutes (0.167 hours) per new user to register on the Exchange or NEUP.gov systems and fill out the requested demographic data. The total estimated annual number of burden hours is 1,513 hours (9,041 users * 0.167 hours); (8) Annual Estimated Reporting and Recordkeeping Cost Burden: $100,000 for changes to systems and approximately $10,000 per year thereafter for maintenance, reporting and record-keeping. Statutory Authority: Section 641 of the Department of Energy Organization Act, codified at 42 U.S.C. 7251. Signed in Washington, DC on January 8, 2020. Emily Stanton, Director of the Office of Strategic Programs, Office of Energy Efficiency and Renewable Energy (EERE). [FR Doc. 2020–02674 Filed 2–10–20; 8:45 am] BILLING CODE 6450–01–P ENVIRONMENTAL PROTECTION AGENCY [EPA–R10–OAR–2019–0702; FRL–10004– 50–Region 10] Completeness Determination; AK: Fairbanks North Star Borough 2006 24Hour Fine Particulate Matter Serious Attainment Plan Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: This notice announces that the Environmental Protection Agency (EPA) has made a determination that the State of Alaska has made a complete Serious Area State Implementation Plan (SIP) submission for the Fairbanks North Star Borough 2006 24-hour fine particulate matter nonattainment area. ADDRESSES: The EPA has established a docket for this notice under Docket ID No. EPA–R10–OAR–2019–0702. All documents in the docket are listed and publicly available at https:// www.regulations.gov. Although listed in the index, some information is not publicly available, i.e., Confidential Business Information or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the internet and will be publicly available only in hard copy form. Publicly available docket khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:19 Feb 10, 2020 Jkt 250001 materials are available electronically at https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Matthew Jentgen at (206) 553–0340, or jentgen.matthew@epa.gov. SUPPLEMENTARY INFORMATION: On December 13, 2019, EPA received the State of Alaska State Implementation Plan to meet the serious area nonattainment plan requirements for purposes of the 2006 24-hour PM2.5 NAAQS in the Fairbanks North Star Borough nonattainment area (‘‘Fairbanks Serious Area Plan’’). The EPA has determined that the submittal of the Fairbanks Serious Area Plan is administratively and technically complete. The EPA made this finding in accordance with section 110(k)(1)(B) and part D of Title I of the Clean Air Act (CAA). The Fairbanks Serious Area Plan submission and a detailed account of Alaska’s SIP submission compared to the completeness criteria in 40 CFR part 51, appendix V, is included in the docket. A completeness determination indicates that the SIP submission meets the minimum criteria that a plan must satisfy for the EPA to review the submittal to determine whether the SIP submission meets the applicable substantive requirements of the CAA and implementing regulations for the type of SIP submission at issue. A completeness determination does not constitute a finding on the merits of the SIP submission or whether it meets the relevant criteria for SIP approval. Consequently, this completeness determination does not constitute final agency action and is not reviewable pursuant to Section 307 of the CAA, 42 U.S.C. 7607, nor section 702 of the Administrative Procedure Act, 5 U.S.C. 702. The EPA’s subsequent rulemaking action or actions on this complete SIP submission will be final agency action, capable of judicial review at the appropriate time. Authority: 42 U.S.C. 7401 et seq. Dated: January 9, 2020. Krishna Viswanathan, Acting Director, Air and Radiation Division, Region 10. (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than March 11, 2020. A. Federal Reserve Bank of St. Louis (David L. Hubbard, Senior Manager) P.O. Box 442, St. Louis, Missouri 63166–2034. Comments can also be sent electronically to Comments.applications@stls.frb.org: 1. The McGehee Bank Employee Stock Ownership Plan, McGehee, Arkansas; to acquire additional voting shares of Southeast Financial Bankstock Corporation, and thereby acquire shares of McGehee Bank, both of McGehee, Arkansas. Board of Governors of the Federal Reserve System, February 5, 2020. Michele Taylor Fennell Assistant Secretary of the Board. [FR Doc. 2020–02647 Filed 2–10–20; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [FR Doc. 2020–00982 Filed 2–10–20; 8:45 am] Notice of Closed Meeting BILLING CODE 6560–50–P Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\11FEN1.SGM 11FEN1 Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–CE–20–003, Research Grants for Preventing Violence and Violence Related Injury. Date: April 1–2, 2020. Time: 8:30 a.m.–5:30 p.m., EDT. Place: Embassy Suites Buckhead, 3285 Peachtree Road NE, Atlanta, GA 30305. Agenda: To review and evaluate grant applications. For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Building 106, MS S106–9, Atlanta, Georgia 30341, Telephone: (770) 488–6562, KLeeks@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–02691 Filed 2–10–20; 8:45 am] applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–OH–20–002, Commercial Fishing Occupational Safety Research Cooperative Agreement; and RFA–OH– 20–003, Commercial Fishing Occupational Safety Training Project Grants. Date: May 12, 2020. Time: 1:00 p.m.–5:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Michael Goldcamp, Ph.D., Scientific Review Officer, Office of Extramural Programs, CDC, 1095 Willowdale Road, Morgantown, West Virginia 26505, Telephone: (304) 285–5951; mgoldcamp@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Program: Protecting Patients from Infections, Antibiotic Resistance and Other Adverse Events; May 21, 2020, 10:00 a.m.–5:00 p.m., (EDT). Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329 which was published in the Federal Register on January 30, 2020, Volume 85, Number 20, page 5440. The meeting is being amended to change the date to May 20–21, 2020. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329, (404) 718–8833, gca5@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2020–02694 Filed 2–10–20; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention khammond on DSKJM1Z7X2PROD with NOTICES Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant VerDate Sep<11>2014 18:19 Feb 10, 2020 Jkt 250001 7761 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CK–20– 004, Prevention Epicenters Program: Protecting Patients From Infections, Antibiotic Resistance and Other Adverse Events Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– CK–20–004, Prevention Epicenters PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–02695 Filed 2–10–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and E:\FR\FM\11FEN1.SGM 11FEN1

Agencies

[Federal Register Volume 85, Number 28 (Tuesday, February 11, 2020)]
[Notices]
[Pages 7760-7761]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02691]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The

[[Page 7761]]

grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-CE-20-003, Research Grants 
for Preventing Violence and Violence Related Injury.
    Date: April 1-2, 2020.
    Time: 8:30 a.m.-5:30 p.m., EDT.
    Place: Embassy Suites Buckhead, 3285 Peachtree Road NE, Atlanta, GA 
30305.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Building 106, MS S106-9, Atlanta, Georgia 30341, Telephone: (770) 488-
6562, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-02691 Filed 2-10-20; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.